Building a Primary Palliative Care Model for Urology Webcast (2021)
Building a Primary Palliative Care Model for Urology Webcast (2021) discusses aspects of palliative care that benefit patients, the urologist’s role and their collaboration with palliative care clinicians including:
The current state of palliative care:
- Evidence for subspecialty-based primary palliative care
- Aspects of palliative care that most benefit patients
- Patient perspective – how doctors can best support patients at the end of life
- Delivery of palliative care services in Urology
When palliative care is needed:
- Panel discussion on identifying the continuum of care, timing, and the extent to which palliative care clinicians should be involved, with emphasis on oncology, stone disease, and female pelvic medicine and reconstructive surgery.
- Non-Urologist (MD or DO)
- Nurse Practitioner
- Physician Assistant
- Practice Manager
At the conclusion of Building a Primary Palliative Care Model for Urology participants will be able to:
- Identify the optimal timing, provider, and support required to support the needs of patients with advanced urologic disease
- Describe the settings in which goals of care, prognosis, diagnosis, advance care planning, goals of operations and procedures, and physical and psychological symptom management are currently being pursued.
- Explain methods of family engagement that support both the family and the patient as disease progresses.
- Discuss aspects of patient care and counseling that are lacking within current health systems.
- Assess the spiritual and support needs among patients with advanced urologic health conditions, and the point along the disease course when this support should be offered.
Current State of Palliative Care:
Moderator Matthew Nielsen, MD, MS, Chair, AUA Quality Improvement and Patient Safety Committee
- Evidence for Subspecialty-based Primary Palliative Care: Katherine Fero, MD
- Aspects of Palliative Care That Most Benefit Patients: Karl Lorenz, MD, MSHS
- Patient Perspective – How Doctors Can Best Support Patients at the End of Life: Renata Louwers
- Delivery of Palliative Care Services in Urology: Jonathan Bergman, MD, MSHS
When is Palliative Care Needed? Panel discussion on identifying the continuum of care, timing, and extent to which palliative care clinicians should be involved:
Moderator Jonathan Bergman, MD, MSHS
- Oncology: Scott Gilbert, MD, MS, Bruce Jacobs, MD
- Stone Disease: Margaret Pearle, MD; John Leppert, MD, MS; Charles Scales, MD, MS
- Female Pelvic Medicine and Reconstructive Surgery: Anne Suskind, MD, MS
- General Urology: Michael Darson, MD
COI Review Work Group Disclosures
COI Review Work Group Disclosures 2021
All relevant disclosures for planners and faculty have been mitigated.
Jonathan Bergman, MD, MPH
John Gore, MD, MS
Matthew Nielsen, MD
Micheal Darson, MD
Katherine Fero, MD, MS
Bruce Jacobs, MD, MPH
John Leppert, MD, MS
Margaret Pearle, MD, PHD
Charles Scales, MD,FACS,MS
Anne Suskind, MD, FACS, MS
Emily Calvert, RN
METHOD OF PARTICIPATION:
Learners will participate in this online educational activity by viewing the webcast and/or listening to the podcast and completing the post-test and evaluation. To claim CME credit for this enduring material, learners must complete the post-test, passing with 80% accuracy, and submit the program evaluation.
Estimated time to complete this activity: 2.00 hours
Release Date: August, 2021
Expiration Date: August, 2024
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Urological Association designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Non-Physician Participation